NCT07127094View on ClinicalTrials.gov

Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

March 9, 2025

Primary Completion Date

June 18, 2025

Study Completion Date

June 18, 2025

Conditions
Bioequivalence Study in Healthy Subjects
Interventions
DRUG

Test Product (Glimcoza)

Tablet formulation

DRUG

Reference (R) Twymeeg®

Tablet formulation

Trial Locations (1)

Unknown

Advanced Research Center (ARC), Cairo

Sponsors
All Listed Sponsors
collaborator

Advanced Research Center (ARC)

UNKNOWN

collaborator

Atco Pharma for Pharmaceutical Industries

UNKNOWN

lead

Aya Mohammed Abdel Magid Abdel Hamid

OTHER

NCT07127094 - Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations | Biotech Hunter | Biotech Hunter